157 related articles for article (PubMed ID: 17960583)
1. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer.
Mortenson MM; Galante JG; Gilad O; Schlieman MG; Virudachalam S; Kung HJ; Bold RJ
J Cell Biochem; 2007 Dec; 102(5):1171-9. PubMed ID: 17960583
[TBL] [Abstract][Full Text] [Related]
2. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
[TBL] [Abstract][Full Text] [Related]
4. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
[TBL] [Abstract][Full Text] [Related]
6. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
7. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism.
Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ
Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815
[TBL] [Abstract][Full Text] [Related]
8. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.
Yang YI; Lee KT; Park HJ; Kim TJ; Choi YS; Shih IeM; Choi JH
Carcinogenesis; 2012 Dec; 33(12):2488-98. PubMed ID: 23027625
[TBL] [Abstract][Full Text] [Related]
9. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.
Saleem M; Kaur S; Kweon MH; Adhami VM; Afaq F; Mukhtar H
Carcinogenesis; 2005 Nov; 26(11):1956-64. PubMed ID: 15958516
[TBL] [Abstract][Full Text] [Related]
10. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF
Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis.
Park ST; Byun HJ; Kim BR; Dong SM; Park SH; Jang PR; Rho SB
Biochem Biophys Res Commun; 2013 May; 435(1):153-9. PubMed ID: 23628417
[TBL] [Abstract][Full Text] [Related]
12. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
[TBL] [Abstract][Full Text] [Related]
13. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis.
Galante JM; Mortenson MM; Bowles TL; Virudachalam S; Bold RJ
J Surg Res; 2009 Mar; 152(1):18-25. PubMed ID: 19062038
[TBL] [Abstract][Full Text] [Related]
14. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation.
Hoffmann R; von Schwarzenberg K; López-Antón N; Rudy A; Wanner G; Dirsch VM; Vollmar AM
Biochem Pharmacol; 2011 Sep; 82(5):453-63. PubMed ID: 21669190
[TBL] [Abstract][Full Text] [Related]
15. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
An J; Chervin AS; Nie A; Ducoff HS; Huang Z
Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
[TBL] [Abstract][Full Text] [Related]
17. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.
Fahy BN; Schlieman MG; Mortenson MM; Virudachalam S; Bold RJ
Cancer Chemother Pharmacol; 2005 Jul; 56(1):46-54. PubMed ID: 15791457
[TBL] [Abstract][Full Text] [Related]
18. Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia.
Vázquez-Franco JE; Reyes-Maldonado E; Vela-Ojeda J; Domínguez-López ML; Lezama RA
Leuk Res; 2012 Jul; 36(7):862-7. PubMed ID: 22591684
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells.
Mochizuki T; Furuta S; Mitsushita J; Shang WH; Ito M; Yokoo Y; Yamaura M; Ishizone S; Nakayama J; Konagai A; Hirose K; Kiyosawa K; Kamata T
Oncogene; 2006 Jun; 25(26):3699-707. PubMed ID: 16532036
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells.
Wang H; Cai J; Du S; Guo Z; Xin B; Wang J; Wei W; Shen X
Cell Biochem Funct; 2017 Aug; 35(6):315-326. PubMed ID: 28845524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]